Enzo Biochem (ENZ) Reports Third Quarter Results
6/11/2013 6:45:29 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Enzo Biochem Inc. (NYSE:ENZ) today reported results for the fiscal third quarter ended April 30, 2013. Among the quarter’s highlights:
•Sequential revenues growth, gross margin improvement and reduced operating loss.
•Following storm-delayed inspection, new diagnostic assays now available to drive revenue growth at Clinical Labs.
Help employers find you! Check out all the jobs and post your resume.